The Growth and Protein Expression of Inflammatory Bowel Disease-Associated Is Affected by the Derivatives of the Food Additive Fumaric Acid
Overview
Authors
Affiliations
Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the gastrointestinal tract with multifactorial etiology. Both dietary factors and the microbe have been found to be associated with the condition. The current study examined the effects of sodium fumarate, a neutralized product of the food additives fumaric acid and monosodium fumarate when in the intestinal environment, on the growth of to determine the effects of these food additives on IBD-associated bacterial species. Through culture methods and quantification, it was found that neutralized fumaric acid, neutralized monosodium fumarate, and sodium fumarate increased the growth of , with the greatest increase in growth at a concentration of 0.4%. Further examination of 50 strains on media with added sodium fumarate showed that greatest growth was also achieved at a concentration of 0.4%. At a concentration of 2% sodium fumarate, all strains examined displayed less growth in comparison with those cultured on media without sodium fumarate. Using mass spectrometry, multiple proteins showed significant differential expression when cultured on media with and without 0.4% sodium fumarate. The findings presented suggest that patients with IBD should consider avoiding excessive consumption of foods with fumaric acid or its sodium salts, and that the addition of 0.4% sodium fumarate alone to media may assist in the isolation of from clinical samples.
Characterization of viable but nonculturable state of .
Wahid S, Campbell B, Moore R, Istivan T R Soc Open Sci. 2024; 11(5):240088.
PMID: 39076798 PMC: 11285765. DOI: 10.1098/rsos.240088.
Analyses of energy metabolism and stress defence provide insights into growth and pathogenicity.
Yeow M, Liu F, Ma R, Williams T, Riordan S, Zhang L Gut Pathog. 2020; 12:13.
PMID: 32165925 PMC: 7059363. DOI: 10.1186/s13099-020-00349-6.
Pathogenomics of Emerging Species.
Costa D, Iraola G Clin Microbiol Rev. 2019; 32(4).
PMID: 31270126 PMC: 6750134. DOI: 10.1128/CMR.00072-18.
The Clinical Importance of and Other Human Hosted Species.
Liu F, Ma R, Wang Y, Zhang L Front Cell Infect Microbiol. 2018; 8:243.
PMID: 30087857 PMC: 6066527. DOI: 10.3389/fcimb.2018.00243.